Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
批准号:
8516601
负责人:
Jack M Parent
金额:
$39.22万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-28 至 2014-07-31
关键词:
AdultAgeAllelesAntiepileptic AgentsAntiepileptogenicAreaAttenuatedBehaviorBehavior assessmentBrainCellsComplementComplexCuesDataDendritesDependenceDevelopmentDisabled PersonsDiseaseDoseElectroencephalographyElectrophysiology (science)EpilepsyEpileptogenesisFrequenciesGoalsGreen Fluorescent ProteinsHilarHippocampus (Brain)HistopathologyHumanImmigrationImpaired cognitionIn VitroInjuryLabelLeadLifeLocationMeasuresMemory LossMemory impairmentModelingNeuronsNewborn InfantOperative Surgical ProceduresPathologyPatientsPharmaceutical PreparationsPilocarpinePlayPropertyRattusRecurrenceRegulationReporterResistanceRodentRoleSeizuresSignal TransductionStagingStatus EpilepticusStructure of molecular layer of cerebellar cortexSyndromeTemporal Lobe EpilepsyTestingTimeTransgenic MiceWorkadult neurogenesisbasecohortdentate gyrusgranule cellinsightirradiationmigrationmossy fibernerve stem cellneuroblastneurogenesisneuron lossnovelnovel therapeuticsoverexpressionpreventprogenitorresearch studyresponsesmall hairpin RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mesial temporal lobe epilepsy (mTLE) is a common epilepsy syndrome that typically manifests with
pharmacoresistant seizures. Histopathology in human and experimental mTLE shows hippocampal pyramidal
and dentate hilar neuron loss, dentate granule cell (DGC) layer dispersion, and DGC axonal remodeling
known as mossy fiber sprouting (MFS). Recent work has uncovered additional pathology involving DGCs in
experimental mTLE: persistent hilar basal dendrites (HBDs) and DGCs in ectopic locations in the hilus and
molecular layer. Remarkably, these abnormalities arise from disordered neurogenesis, as DGC neurogenesis
persists throughout life. These findings have led to the idea that epileptogenic insults result in the aberrant
integration of newborn DGCs. This idea is supported by morphological and electrophysiological evidence that
aberrant neurogenesis induces network hyperexcitability. Other work, in contrast, suggests that normally
integrated adult-born DGCs compensate for epileptogenic hyperexcitability by restoring inhibition after status
epilepticus (SE)-induced injury.
Using the rat pilocarpine epilepsy model, we recently discovered that only developing, and not mature,
DGCs are responsible for abnormal DGC plasticity during epileptogenesis, including MFS and the presence of
HBDs and ectopic DGCs. Data from our lab and others also suggest that reduced expression of the secreted
developmental cue reelin in epileptic hippocampus contributes to aberrant neuroblast migration in experimental
mTLE, and DGC layer dispersion in human mTLE. Based on these data, we propose to test the following
hypotheses: 1) Only DGCs not fully mature at the time of injury or those generated after injury are vulnerable
to SE-induced plasticity, and loss of dentate gyrus reelin expression underlies some forms of this plasticity; and
2) Most vulnerable DGCs or their progenitors integrate abnormally during epileptogenesis, leading to
hippocampal hyperexcitability and seizures; blocking neurogenesis or aberrant DGC integration therefore will
ameliorate the epileptic state. We propose 3 specific aims to test these hypotheses. Aim 1 is to determine
whether altered reelin signaling leads to aberrant DGC progenitor migration or HBD formation in the intact or
epileptic dentate gyrus. Aim 2 is to characterize the vulnerability of DGCs at different developmental stages
(ranging from mature at SE to those born after SE) to SE-induced plasticity, and to examine intrinsic properties
and network influences of developing DGCs integrating normally or aberrantly during epileptogenesis. In Aim
3, we propose to determine whether attenuating aberrant integration of developing DGCs will suppress
epileptogenesis. Progress in these aims will provide insight into the regulation of adult neurogenesis, will
determine the functional role of aberrant neurogenesis in epilepsy, and may lead to novel therapeutic
strategies to inhibit epileptogenesis or cognitive impairment in mTLE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Proteins to Cell Systems
-
批准号:10670368
-
项目类别:
-
资助金额:$45.6万
-
财政年份:2020
-
负责人:Jack M Parent
-
依托单位:
Proteins to Cell Systems
-
批准号:10265442
-
项目类别:
-
资助金额:$44.74万
-
财政年份:2020
-
负责人:Jack M Parent
-
依托单位:
Proteins to Cell Systems
-
批准号:10455558
-
项目类别:
-
资助金额:$45.59万
-
财政年份:2020
-
负责人:Jack M Parent
-
依托单位:
2014 Mechanisms of Epilepsy and Neuronal Synchronization Gordon Research Conferen
-
批准号:8780847
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2014
-
负责人:Jack M Parent
-
依托单位:
Adult Neurogenesis and Stroke Recovery
-
批准号:8998986
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Jack M Parent
-
依托单位:
Adult Neurogenesis and Stroke Recovery
-
批准号:8978329
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Jack M Parent
-
依托单位:
Neural Progenitor Grafting for Restorative Stroke Therapy
-
批准号:7909154
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2010
-
负责人:Jack M Parent
-
依托单位:
Neural Progenitor Grafting for Restorative Stroke Therapy
-
批准号:8606262
-
项目类别:
-
资助金额:$32.33万
-
财政年份:2010
-
负责人:Jack M Parent
-
依托单位:
Neural Progenitor Grafting for Restorative Stroke Therapy
-
批准号:8016596
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2010
-
负责人:Jack M Parent
-
依托单位:
Neural Progenitor Grafting for Restorative Stroke Therapy
-
批准号:8417716
-
项目类别:
-
资助金额:$31.51万
-
财政年份:2010
-
负责人:Jack M Parent
-
依托单位:
Neural Progenitor Grafting for Restorative Stroke Therapy
-
批准号:8214642
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2010
-
负责人:Jack M Parent
-
依托单位:
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
-
批准号:8502097
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2009
-
负责人:Jack M Parent
-
依托单位:
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
-
批准号:7800617
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2009
-
负责人:Jack M Parent
-
依托单位:
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
-
批准号:8113458
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2009
-
负责人:Jack M Parent
-
依托单位:
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
-
批准号:8310029
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2009
-
负责人:Jack M Parent
-
依托单位:
Aberrant Neurogenesis in Experimental Temporal Lobe Epilepsy
-
批准号:7939891
-
项目类别:
-
资助金额:$31.73万
-
财政年份:2009
-
负责人:Jack M Parent
-
依托单位:
Zebrafish Models to Study Adult Forebrain Neurogenesis
-
批准号:7535094
-
项目类别:
-
资助金额:$18.92万
-
财政年份:2008
-
负责人:Jack M Parent
-
依托单位:
Augmentation of Neurogenesis and Recovery After Stroke
-
批准号:6677078
-
项目类别:
-
资助金额:$24.28万
-
财政年份:2003
-
负责人:Jack M Parent
-
依托单位:
Augmentation of Neurogenesis and Recovery After Stroke
-
批准号:6914830
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2003
-
负责人:Jack M Parent
-
依托单位:
Augmentation of Neurogenesis and Recovery After Stroke
-
批准号:6784212
-
项目类别:
-
资助金额:$23.53万
-
财政年份:2003
-
负责人:Jack M Parent
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: